Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 71, Issue 1, Pages 45-55Publisher
SPRINGER
DOI: 10.1007/s00262-021-02960-1
Keywords
Gastric cancer; Neoadjuvant chemotherapy; Predictive factors; Precision medicine; Immunological status
Categories
Funding
- Universita Cattolica del Sacro Cuore within the CRUI-CARE Agreement
- Universita Cattolica del Sacro Cuore, Fondi d'Ateneo, Linea D1
Ask authors/readers for more resources
The study found that pre-treatment NLR, TILs, and PD-L1 expression are correlated with the response to neoadjuvant chemotherapy and prognosis in LAGC patients, suggesting their significance in selecting patients for chemotherapy.
The combination of perioperative chemotherapy plus complete surgical resection is currently accounted as the first-choice strategy in patients with locally advanced Gastric Cancer (LAGC). Nevertheless, the partial response rate makes it necessary to search biological parameters useful to select patients who would benefit most from neoadjuvant chemotherapy (NAD-CT). We performed a retrospective analysis on a cohort of 65 LAGC cases, EBV negative and without MMR defect, submitted to perioperative chemotherapy plus surgical resection. We evaluated the neutrophil-lymphocytes ratio (NLR) in peripheral blood, the TILs density (reported as CD4/CD8 tissue ratio) and PD-L1 expression by immunohistochemistry on bioptic tissues before the treatment. Results were correlated with the biological features, histological response (TRG) and clinical outcome (PFS and OS). We found that NLR, TILs and PD-L1 expression showed a significant correlation with TNM stage, lymphovascular invasion and response to NAD-CT (TRG). Correlating the NLR, TILs and PD-L1 expression with PFS and OS, we found that patients with lower NLR levels (< 2.5 ratio), lower TILs (< 0.2 ratio) and higher PD-L1 level (CPS >= 1) had a significantly better PFS and OS than those with higher NLR, higher TILs and lower PD-L1 expression (p < 0.0001). Multivariate and multiple regression analyses confirmed the predictive and prognostic role of all three parameters, especially when all three parameters are combined. Our study demonstrated that pre-treatment NLR, TILs and PD-L1 expression are predictive and prognostic parameters in NAD-CT-treated LAGC suggesting a pivotal role of the systemic and tumor microenvironment immunological profile in the response to chemotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available